Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 23431
Gene Symbol: AP4E1
AP4E1
0.110 Biomarker phenotype HPO
Entrez Id: 1107
Gene Symbol: CHD3
CHD3
0.100 Biomarker phenotype HPO
Entrez Id: 4137
Gene Symbol: MAPT
MAPT
0.100 Biomarker phenotype HPO
Entrez Id: 57410
Gene Symbol: SCYL1
SCYL1
0.100 Biomarker phenotype HPO
Entrez Id: 1738
Gene Symbol: DLD
DLD
0.010 Biomarker phenotype BEFREE At the outset of this article, we posed the question of whether or not the current evidence from genetic studies of DLD and stuttering indicate that it would be fruitful to conduct studies aimed at determining the gene location for each of these disorders. 1408200 1992
Entrez Id: 93986
Gene Symbol: FOXP2
FOXP2
0.030 GeneticVariation phenotype BEFREE After completing this paper, readers should be able to (a) identify key epidemiological findings for the three speech phenotypes that were discussed (DAS, speech delay, and stuttering); (b) summarize the findings of the behavioral genetic studies of speech disorders that were presented; (c) identify four specific challenges that may impede future molecular genetic studies of these phenotypes; (d) describe the methodological sequence that led to the discovery of the FOXP2 gene; and (e) summarize the two research strategies that were presented to potentially reduce sample heterogeneity for future molecular genetics research. 12160352 2003
Entrez Id: 6006
Gene Symbol: RHCE
RHCE
0.010 GeneticVariation phenotype BEFREE Evidence is presented that RHD, RHCE, and other RH genes, may be interesting candidates to consider when searching for the genetic basis of hair whorl rotation (i.e., clockwise or counterclockwise), handedness (i.e., right handed, left handed or ambidextrous), speech laterality (i.e., right brained or left brained), speech dyslexia (e.g., stuttering), sexual orientation (i.e., heterosexual, homosexual, bisexual, or transsexual), schizophrenia, bipolar disorder, and autism spectrum disorder. 16337093 2006
Entrez Id: 1812
Gene Symbol: DRD1
DRD1
0.010 GeneticVariation phenotype BEFREE We report here the effect of maternal age and the age of the mother at the birth of her first child (maternal age 1st) as epistatic factors for the interaction of the dopamine D1 gene (DRD1) with obsessive-compulsive behaviors and with stuttering. 16342283 2006
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.030 Biomarker phenotype BEFREE Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese. 19590515 2009
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.010 Biomarker phenotype BEFREE Association between dopaminergic genes (SLC6A3 and DRD2) and stuttering among Han Chinese. 19590515 2009
Entrez Id: 79158
Gene Symbol: GNPTAB
GNPTAB
0.040 GeneticVariation phenotype BEFREE This and three other mutations in GNPTAB occurred in unrelated subjects with stuttering but not in control subjects. 20147709 2010
Entrez Id: 1798
Gene Symbol: DPAGT1
DPAGT1
0.010 GeneticVariation phenotype BEFREE We identified a missense mutation in the N-acetylglucosamine-1-phosphate transferase gene (GNPTAB), which encodes the alpha and beta catalytic subunits of GlcNAc-phosphotransferase (GNPT [EC 2.7.8.15]), that was associated with stuttering in a large, consanguineous Pakistani family. 20147709 2010
Entrez Id: 26047
Gene Symbol: CNTNAP2
CNTNAP2
0.320 Biomarker phenotype CTD_human CNTNAP2 is known to be involved in the cause of language and speech disorders and autism spectrum disorder and is in the same pathway as FOXP2, another important language gene, which makes it a candidate gene for causal studies speech and language disorders such as stuttering. 21108403 2010
Entrez Id: 26047
Gene Symbol: CNTNAP2
CNTNAP2
0.320 Biomarker phenotype BEFREE CNTNAP2 is known to be involved in the cause of language and speech disorders and autism spectrum disorder and is in the same pathway as FOXP2, another important language gene, which makes it a candidate gene for causal studies speech and language disorders such as stuttering. 21108403 2010
Entrez Id: 93986
Gene Symbol: FOXP2
FOXP2
0.030 Biomarker phenotype BEFREE CNTNAP2 is known to be involved in the cause of language and speech disorders and autism spectrum disorder and is in the same pathway as FOXP2, another important language gene, which makes it a candidate gene for causal studies speech and language disorders such as stuttering. 21108403 2010
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 GeneticVariation phenotype BEFREE These biochemical findings extend the genetic data implicating mutations in the NAGPA gene in the persistent stuttering phenotype. 21956109 2011
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.030 GeneticVariation phenotype BEFREE This idea is supported by an additional path model showing that the polymorphism DRD2 C957T influences the self-reported severity of stuttering mainly by its influence on neuroticism (independent of the variable sex). 22262089 2012
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 GeneticVariation phenotype BEFREE Surprisingly, the first variant genes to be associated with stuttering are those encoding the lysosomal targeting system, GNPTAB, GNPTG, and NAGPA. 22884963 2012
Entrez Id: 79158
Gene Symbol: GNPTAB
GNPTAB
0.040 GeneticVariation phenotype BEFREE Surprisingly, the first variant genes to be associated with stuttering are those encoding the lysosomal targeting system, GNPTAB, GNPTG, and NAGPA. 22884963 2012
Entrez Id: 26047
Gene Symbol: CNTNAP2
CNTNAP2
0.320 Biomarker phenotype BEFREE This study provides an improved estimate of the contribution of mutations in GNPTAB, GNPTG and NAGPA to persistent stuttering, and suggests that variants in FOXP2 and CNTNAP2 are not involved in the genesis of familial persistent stuttering. 24807205 2014
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 Biomarker phenotype BEFREE This was compared to the distribution of variants in the GNPTAB, GNPTG, and NAGPA genes which have previously been associated with persistent stuttering. 24807205 2014
Entrez Id: 93986
Gene Symbol: FOXP2
FOXP2
0.030 GeneticVariation phenotype BEFREE This study provides an improved estimate of the contribution of mutations in GNPTAB, GNPTG and NAGPA to persistent stuttering, and suggests that variants in FOXP2 and CNTNAP2 are not involved in the genesis of familial persistent stuttering. 24807205 2014
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 GeneticVariation phenotype BEFREE Our results revealed that the stuttering risk genes GNPTAB and NAGPA might also associate with developmental dyslexia in the Chinese population. 25643770 2015
Entrez Id: 79158
Gene Symbol: GNPTAB
GNPTAB
0.040 GeneticVariation phenotype BEFREE Our results revealed that the stuttering risk genes GNPTAB and NAGPA might also associate with developmental dyslexia in the Chinese population. 25643770 2015
Entrez Id: 51172
Gene Symbol: NAGPA
NAGPA
0.060 Biomarker phenotype BEFREE Recently, variants in GNPTAB, GNPTG, and the functionally related NAGPA gene have been associated with non-syndromic persistent stuttering. 26130485 2016